Wow_老虎社区_美港股上老虎

2021-07-28

Wow

Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":803192165,"tweetId":"803192165","gmtCreate":1627427169857,"gmtModify":1633765217806,"author":{"id":4089409912576010,"idStr":"4089409912576010","authorId":4089409912576010,"authorIdStr":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Wow&nbsp;</body></html>","htmlText":"<html><head></head><body>Wow&nbsp;</body></html>","text":"Wow","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/803192165","repostId":1134472085,"repostType":4,"repost":{"id":"1134472085","kind":"news","pubTimestamp":1627398407,"share":"https://www.laohu8.com/m/news/1134472085?lang=zh_CN&edition=full","pubTime":"2021-07-27 23:06","market":"us","language":"en","title":"Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134472085","media":"TheStreet","summary":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. ","content":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.<blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.<blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.<blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote> The cannabis market<blockquote>大麻市场</blockquote> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.<blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.<blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote> <img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\">Figure 1: Annual growth of the U.S legal cannabis industry.<blockquote>图1：美国合法大麻产业的年增长率。</blockquote> Tilray + Aphria merger<blockquote>Tilray + Aphria 合并</blockquote> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.<blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote> The Tilray-Aphria merger was justified by expected benefits that included:<blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote> <ol> <li>market leadership in Canada</li> <li>foothold in Europe and better positioning in the U.S.</li> <li>lower production costs and synergies</li> </ol> <img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\">Figure 2: Aphria + Tilray merger.<blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol>图2：Aphria+Tilray合并。</blockquote> Wall Street's take<blockquote>华尔街的观点</blockquote> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:<blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote> <img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\">Figure 3: Tilray earnings and revenues.<blockquote>图 3：Tilray 盈利和收入。</blockquote> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.<blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:<blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote> \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.” Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.<blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote> Reddit popularity<blockquote>Reddit 人气</blockquote> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.<blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.<blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.<blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote> <img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\">Figure 4: TLRY stock sentiment and popularity on the WSB.<blockquote>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</blockquote> Wall Street Memes’ take<blockquote>华尔街迷因的看法</blockquote> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.<blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.<blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nTheStreet2021-07-27 23:06\n\n</h4>\n</header>\n<article>\nOn Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.<blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.<blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.<blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote> The cannabis market<blockquote>大麻市场</blockquote> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.<blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.<blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote> <img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\">Figure 1: Annual growth of the U.S legal cannabis industry.<blockquote>图1：美国合法大麻产业的年增长率。</blockquote> Tilray + Aphria merger<blockquote>Tilray + Aphria 合并</blockquote> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.<blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote> The Tilray-Aphria merger was justified by expected benefits that included:<blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote> <ol> <li>market leadership in Canada</li> <li>foothold in Europe and better positioning in the U.S.</li> <li>lower production costs and synergies</li> </ol> <img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\">Figure 2: Aphria + Tilray merger.<blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol>图2：Aphria+Tilray合并。</blockquote> Wall Street's take<blockquote>华尔街的观点</blockquote> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:<blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote> <img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\">Figure 3: Tilray earnings and revenues.<blockquote>图 3：Tilray 盈利和收入。</blockquote> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.<blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:<blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote> \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.” Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.<blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote> Reddit popularity<blockquote>Reddit 人气</blockquote> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.<blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.<blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.<blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote> <img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\">Figure 4: TLRY stock sentiment and popularity on the WSB.<blockquote>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</blockquote> Wall Street Memes’ take<blockquote>华尔街迷因的看法</blockquote> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.<blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.<blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings\">TheStreet</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134472085","content_text":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.\nDrug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.\nThe stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.\nThe cannabis market\nIn the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according to the latest data.\nIn 2020, the cannabis market was estimated to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.\nFigure 1: Annual growth of the U.S legal cannabis industry.\nTilray + Aphria merger\nTilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.\nThe Tilray-Aphria merger was justified by expected benefits that included:\n\nmarket leadership in Canada\nfoothold in Europe and better positioning in the U.S.\nlower production costs and synergies\n\nFigure 2: Aphria + Tilray merger.\nWall Street's take\nIn the past several quarters, Tilray has been making good strides on its P&L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:\nFigure 3: Tilray earnings and revenues.\nAnalysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.\nDespite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen & Co.’s analyst maintained her buy recommendation, but stated the following about Tilray:\n\n \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”\n\nAlliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.\nReddit popularity\nTilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.\nThe drivers of bullishness were (1) good earnings results, (2) favorable developments in cannabis regulation, and (2) the signed agreement with Grow Pharma to distribute medical cannabis for patients in the U.K.\nReddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.\nFigure 4: TLRY stock sentiment and popularity on the WSB.\nWall Street Memes’ take\nThe cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.\nAt the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.","news_type":1,"symbols_score_info":{"TLRY":0.9}},"isVote":1,"tweetType":1,"viewCount":2085,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/803192165"}